This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Discover what are different investing strategies and how they can help you succeed in your investment journey.
18,703 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
As markets heat up this summer, here's this tech stock stands out for its AI-focused growth story, solid finances, an...
Modine Manufacturing sits at a compelling crossroads as data centers expand. This primer outlines why investors may w...
AI-driven disruption could displace millions of American workers. This report outlines the scale, policy options, and...
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...
A big open-market purchase by Gibraltar Industries' CEO has traders buzzing. This article breaks down what the move m...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
Extreme role prep can demand big money and careful planning. This article breaks down how to budget for a major fitne...
The AI race is heating up, and anthropic (claude) only trillion is a headline that won’t fade. This article breaks do...
Marvell Technology jumped on news it will join the S&P 500, triggering bullish moves in chips and AI infrastructure p...
Broadcom stock surged on AI optimism, then slipped after earnings. This guide explains how to evaluate a dip, what ri...
C3.AI stock has shed shares in 2026, but that drop raises the question: is this a buying opportunity or a trap? This ...